نتائج البحث

Stability indicating RP-UPLC determination of three antiviral agents: emtricitabine, tenofovir, and rilpivirine in combined pharmaceutical dosage form.

• Authors : Kommineni, Vinutha¹ (AUTHOR) ; Pohar, Spoorthi¹ (AUTHOR); Lakshmi, N. Sri¹ (AUTHOR)

• Source: Future Journal of Pharmaceutical Sciences. 2/17/2025, Vol. 11 Issue 1, p1-10. 10p.

تفاصيل العنوان

The impact of adherence counseling incorporating a point of care urine tenofovir assay on virologic suppression among individuals failing tenofovir-lamivudine-dolutegravir: A pre-post intervention study.

• Authors : Bikinesi, Leonard; Spinelli, Matthew; Nyoni, Ntombizodwa

Subjects: Enhanced adherence counseling; Namibia; People living with HIV

تفاصيل العنوان

Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)

• Source: Phase IIb, Double-Blinded, Multicenter, Randomized Study to Assess the Effect on Central Nervous System (CNS) Toxicity of Switching From ATRIPLA™ (Efavirenz,

تفاصيل العنوان

Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF.

• Authors : Kim H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaruro, Wonmigu, Bucheon, Gyeonggido, 14584, Republic of Korea.; Kim JY

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/epidemiology ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use

• Source: Scientific reports [Sci Rep] 2025 Feb 15; Vol. 15 (1), pp. 5637. Date of Electronic Publication: 2025 Feb 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B.

• Authors : Matsubara T; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka- Sayama, Osaka, 589-8511, Japan.; Hagiwara S

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; Drug Substitution*

• Source: Scientific reports [Sci Rep] 2025 Jan 06; Vol. 15 (1), pp. 869. Date of Electronic Publication: 2025 Jan 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.

• Authors : Merchant, Elisabeth^1,2 (AUTHOR) ; Solleveld, Patricia³ (AUTHOR); Gibas, Kevin^4,5 (AUTHOR)

Subjects: *MEDICAL personnel; *PRE-exposure prophylaxis; *EMTRICITABINE-tenofovir

• Source: PLoS ONE. 12/5/2024, Vol. 19 Issue 12, p1-14. 14p.

تفاصيل العنوان

A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participants

• Source: A Single-Dose, Open-Label, Randomized, Crossover Study to Assess the Bioequivalence of Darunavir 800 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 10 mg, in the

تفاصيل العنوان

Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries.

• Authors : Nka AD; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon.; Bouba Y

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; HIV-1*/HIV-1*/HIV-1*/drug effects

• Source: Viruses [Viruses] 2025 Jan 06; Vol. 17 (1). Date of Electronic Publication: 2025 Jan 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV.

• Authors : Barroso, Sergio^1,2,3 (AUTHOR) ; Guitart-Mampel, Mariona^1,2,3 (AUTHOR) ; García-García, Francesc Josep^1,2,3 (AUTHOR)

Subjects: *CYTOCHROME oxidase; *HIV infections; *HIV-positive persons

• Source: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8418. 17p.

تفاصيل العنوان

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies

• Authors : Landovitz, Raphael J; Tao, Li; Yang, Juan

Subjects: Medical Microbiology; Biomedical and Clinical Sciences; Clinical Sciences

• Source: Clinical Infectious Diseases. 79(5)

تفاصيل العنوان